Jeffrey Anderson
Reva Medical (United States)(US)Temple University Hospital(US)
Publications by Year
Research Areas
Coronary Interventions and Diagnostics, Hepatocellular Carcinoma Treatment and Prognosis, Cancer Immunotherapy and Biomarkers, Cardiac Imaging and Diagnostics, Cardiac Valve Diseases and Treatments
Most-Cited Works
- → Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial(2017)4,261 cited
- → Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib(2020)1,179 cited
- → CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)(2019)644 cited
- → Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis(2019)268 cited
- → A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection(2013)227 cited
- → Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification(2022)226 cited